4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide

Discontinued Product

0466 has been discontinued.

View all Non-selective Muscarinics products.
说明: Partial agonist at ganglionic M1 receptor
说明书
引用文献
评论
文献 (1)

生物活性

A partial agonist with 16 times the power of the analogue McN-A-343 in increasing arterial blood pressure and 18 times the affinity of the latter for ganglionic M1 receptors.

技术数据

分子量 422.69
储存 Store at RT
CAS Number 141063-77-6

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书

分析证书目前不在网上提供。
请联系客户服务

参考文献

参考文献是支持产品生物活性的出版物。

Nilsson et al (1992) Amide, urea and carbamate analogues of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride. J.Med.Chem. 35 2787 PMID: 1379640

按产品操作查看相关产品

查看全部 Non-selective Muscarinic Agonists

关键词: 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethylammonium iodide, 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethylammonium iodide supplier, Non-selective, Muscarinics, 0466, Tocris Bioscience

篇 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide 的引用文献。

4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide 的评论

目前没有该产品的评论。 Be the first to review 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide and earn rewards!

Have you used 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.